Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explains why air matters, for everybody, everywhere (H2)
Helen McShane, Professor of Vaccinology at The Jenner Institute, University of Oxford reveals the current status of tuberculosis vaccine development in the world today.
Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today
Leora Fox, Jennifer Simpson and George Yohrling from the Huntington’s Disease Society of America explore the sources of funding in the development of therapies for Huntington’s disease (HD).
Today, The Aplastic Anaemia Trust (AAT) launches their new research strategy, inviting prospective applicants to come forward with proposals for truly translational research into aplastic anaemia (AA), as CEO Grazina Berry reveals
Associate Professor and Director of Medical School Curriculum at the University of Illinois, Dr Ahlke Heydemann underlines Duchenne muscular dystrophy (DMD) – a debilitating, progressive muscle weakening disease.
A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
Professor Pierre Ronco describes advances in our understanding of membranous nephropathy and the promise of precision medicine to treat the disease
A rare disease which...
Professor Serena Carra and her collaborators are investigating the important role of small heat shock proteins in age-related neurodegenerative diseases
Cells are frequently exposed to...
Open Access Government looks at how health research can play a pivotal role in preventing major diseases throughout the country
Over the decades we have...
